BioGX | WebDisclosure

Switch to English

9472	Sociétés
185370	Mots-clés
117721	Articles
99262	Communiqués

COMMUNIQUÉ DE PRESSE

publié le 11/01/2024 à 18:00, il y a 1 année 10 mois

BioGX Expands PCR Test Menu at State Departments of Health
BioGX, a leading provider of molecular diagnostic solutions, has announced the expansion of its test menu to support state Departments of Health with the addition of its Candida auris assay. This expansion will provide access to BioGX's molecular assays designed for speed, precision, and reliability, empowering healthcare professionals with the best tools available to improve public health outcomes.

Healthcare Professionals BioGX Molecular Diagnostic Solutions Candida Auris Assay Public Health
COMMUNIQUÉ DE PRESSE

publié le 24/07/2023 à 06:00, il y a 2 années 4 mois

BioGX Candida Auris PCR Assay Global Adoption Accelerates
COMMUNIQUÉ DE PRESSE

publié le 23/03/2023 à 19:00, il y a 2 années 8 mois

BioGX Candida Auris PCR Assay Adoption Accelerates
COMMUNIQUÉ DE PRESSE

publié le 28/02/2023 à 21:00, il y a 2 années 9 mois

BioGX Ships First Batch of pixl(TM) Real-Time PCR Platform to US Laboratories

Les Echos

Publié le 04/12/2025 à 18:14, il y a 13 heures 38 minutes

Résiliation d'une convention conclue entre actionnaires
Publié le 04/12/2025 à 18:00, il y a 13 heures 53 minutes

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Publié le 04/12/2025 à 18:00, il y a 13 heures 53 minutes

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Publié le 04/12/2025 à 17:45, il y a 14 heures 8 minutes

Informations relatives au nombre total de droits de vote et d’actions
Publié le 04/12/2025 à 17:45, il y a 14 heures 8 minutes

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 05/12/2025 à 02:35, il y a 5 heures 18 minutes

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Publié le 05/12/2025 à 02:30, il y a 5 heures 23 minutes

Klondike Gold Announces AGM Results
Publié le 05/12/2025 à 01:00, il y a 6 heures 53 minutes

BEACN Closes First Tranche of Non-Brokered Private Placement
Publié le 04/12/2025 à 23:05, il y a 8 heures 48 minutes

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Publié le 04/12/2025 à 23:00, il y a 8 heures 53 minutes

NXT Energy Solutions Completes Data Acquisition for SFD Survey

Voir tout ACCESSWIRE

EQS Group

Publié le 05/12/2025 à 07:00, il y a 52 minutes

Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Publié le 05/12/2025 à 03:30, il y a 4 heures 22 minutes

CGTN: What makes cooperation between China and France a two-way success
Publié le 04/12/2025 à 23:50, il y a 8 heures 2 minutes

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Publié le 04/12/2025 à 20:25, il y a 11 heures 27 minutes

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Publié le 04/12/2025 à 20:15, il y a 11 heures 37 minutes

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025